Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Willén

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 29, 2014
The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximabAke Berglund, Linda Willén, Lina Grödeberg, et al.
Plos One|December 15, 2022
Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden)Linda Willén, Anders Berglund, Stefan Bergström, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2021
Are older patients with non-small cell lung cancer receiving optimal care? A population-based studyLinda Willén, Anders Berglund, Stefan Bergström, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based studyLinda Willén, Anders Berglund, Stefan Bergström, et al.
Cancer Treatment and Research Communications|April 16, 2022
Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancerJohan Isaksson, Leo Wennström, Eva Branden, et al.
Translational Lung Cancer Research|July 17, 2025
Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer-a retrospective cohort studyErika Broström, Johan Isaksson, Panagiotis Xanthoulis, et al.
Clinical Lung Cancer|June 9, 2023
KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer RegistryJohan Isaksson, Anders Berglund, Karly Louie, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|May 29, 2014
The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximabAke Berglund, Linda Willén, Lina Grödeberg, et al.
Plos One|December 15, 2022
Patterns of care and outcomes in immigrants with non-small cell lung cancer. A population-based study (Sweden)Linda Willén, Anders Berglund, Stefan Bergström, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2021
Are older patients with non-small cell lung cancer receiving optimal care? A population-based studyLinda Willén, Anders Berglund, Stefan Bergström, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based studyLinda Willén, Anders Berglund, Stefan Bergström, et al.
Cancer Treatment and Research Communications|April 16, 2022
Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancerJohan Isaksson, Leo Wennström, Eva Branden, et al.
Translational Lung Cancer Research|July 17, 2025
Predictors of survival and recurrence patterns following definitive chemoradiotherapy in stage III non-small cell lung cancer-a retrospective cohort studyErika Broström, Johan Isaksson, Panagiotis Xanthoulis, et al.
Clinical Lung Cancer|June 9, 2023
KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer RegistryJohan Isaksson, Anders Berglund, Karly Louie, et al.
Pageof 1